Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05591911 · ClinicalTrials.gov registry record
Urine Gene Analysis for Pathogen Detection
A clinical trial of Urinary Tract Infections, sponsored by David Sheyn.
- Completed
- Registry status
- 96
- Enrollment target
- 1
- Study location
NCT05591911 is a study of Urinary Tract Infections that has completed, run by David Sheyn. The registered enrollment target is 96 participants, below the 456-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05591911, a study of Urinary Tract Infections, has completed, sponsored by David Sheyn.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is the detection, quantification, and resistance gene identification of pathogens by using the urine of patients with urinary tract infection (UTI) symptoms.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Urine PCR testing
Study Locations (1)
Ohio
- University Hospitals - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2023-06-25 |
| Est. Completion | 2024-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05591911
The ClinicalTrials.gov registry entry for NCT05591911 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 456-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (79% lower). The listed sponsor is David Sheyn, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Tract Infections appearing as the primary indexed condition, and to 1 intervention - of which Urine PCR testing is the first listed.
NCT05591911 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05591911 about?
NCT05591911 is a clinical study titled "Urine Gene Analysis for Pathogen Detection". The objective of this study is the detection, quantification, and resistance gene identification of pathogens by using the urine of patients with urinary tract infection (UTI) symptoms.
What is the current status of trial NCT05591911?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2023-06-25. Estimated completion is 2024-08-31.
What conditions does trial NCT05591911 study?
This clinical trial studies the following conditions: Urinary Tract Infections.
What interventions are being tested in trial NCT05591911?
The interventions under investigation include: Urine PCR testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05591911?
This trial is sponsored by David Sheyn, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05591911 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age
RECRUITING · Phase 1
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
NextGen - Clinical Implication of Next Generation Sequencing
RECRUITING · Phase 4
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Single Dose Amikacin for Uncomplicated Cystitis in the ED: A Feasibility Study
RECRUITING
-
A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.